Eukaryotic translation initiation factor 2A pseudogene 4 (EIF2AP4)

EIF2AP4 stands for eukaryotic translation initiation factor 2A pseudogene 4, which is classified as a pseudogene in the human genome[5]. Pseudogenes are segments of DNA that resemble genes but are not functional; they typically lack the capacity to code for a functional protein due to mutations or truncations[5]. There is no evidence in authoritative sources that EIF2AP4 encodes a protein product, has any recognized biological function, or is implicated in any disease roles, nor is it considered a therapeutic target. No interacting drugs, mechanisms of action, or biomarker associations are reported in relation to EIF2AP4; therefore, it does not fit the criteria for a molecule or receptor relevant to therapeutic targeting. Note: - This designation is distinct from true translation initiation factors (like EIF2A or EIF2S1) that participate in protein synthesis. - The abbreviation "EIF2AP4" refers specifically to this pseudogene and should not be confused with bona fide translation initiation factors or their functional protein products[5]. - The inclusion of "pseudogene" in the name clearly indicates its non-functional nature. Summary: EIF2AP4 is a pseudogene, not a functional molecule or therapeutic target, and has no established biological or pharmacological role[5].

Other names

EIF2AP4